Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Mental Health
Psychedelic Alpha

Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona

JoshNovember 3, 20261 min read
Curated by Paradise Farmers Market

This morning, Compass Pathways shared its Q3 2026 results, which included an update on its COMP360 psilocybin for treatment-resistant depression (TRD) new drug application (NDA) submission. “Final NDA submission nearing completion,” the first bullet point in the release states, “and will be filed in the next two weeks.” “With the imminent completion of our NDA submission and the potential for a…

Read the full story

Continue reading at Psychedelic Alpha

Read Original

Originally reported by Josh at Psychedelic Alpha

Paradise Farmers Market curates content for educational purposes.